Clinical Trial Update: Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing adalimumab plus methotrexate versus methotrexate alone in subjects with early rheumatoid arthritis showed efficacy and safety outcomes f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Humira (adalimumab)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Early Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2010-02-25